Komori
Fuji Pharma (4554) · PolicyFirst stated

Emphasis on Compliance and Accurate Information Disclosure as a Pharmaceutical Company

First written in FY2017. . Latest entry: FY2017.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Compliance as a Listed Company and Timely, Appropriate Information DisclosureA theme 107 companies write about · 0 as a headwind · 108 as a tailwind

7 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 107 companies compared. The sentences above are computed from all 107.
Full recordFilings, disclosures and news, newest first
  1. FY2017First statedAnnual report

    「As a company engaged in the manufacture and sale of pharmaceuticals, a business directly affecting human life, we believe that it is essential to manage the company with an emphasis on compliance with applicable laws and regulations, including the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, and to establish corporate governance to implement this approach.」

    For the first time, creates a thread on the policy of emphasizing compliance and establishing corporate governance in light of the characteristics of the pharmaceutical business.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.